Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Edwards

Showing results (1211-1220 of 1,253) with videos related to

Pageof 126
Sort By:
Epidemiology (Cambridge, Mass.)|March 24, 2025
Right Censoring and Mortality in the Multicenter AIDS Cohort Study and Women's Interagency HIV StudyJessie K Edwards, Tiffany L Breger, Stephen R Cole, et al.
Implementation Science Communications|July 28, 2025
Study design and procedures for a hybrid effectiveness-implementation incomplete stepped-wedge cluster-randomized trial to evaluate a differentiated point-of-care HIV diagnosis and management model for the prevention of vertical transmission of HIV in Malawi: The PAC-Man trial protocolMichael E Herce, Caitlin Cassidy, Alexandra Munson, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Nature Communications|July 8, 2021
The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the CongoNicholas F Brazeau, Cedar L Mitchell, Andrew P Morgan, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
JAMA Network Open|October 13, 2022
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the USRaynell Lang, Elizabeth Humes, Sally B Coburn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2025
Incidence of statin initiation among people with and without HIV in the US: a prospective observational studyTiffany L Breger, Daniel J Westreich, Andrew Edmonds, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Pageof 126

Showing results (1211-1220 of 1,253) with videos related to

Sort By:
Pageof 126
Epidemiology (Cambridge, Mass.)|March 24, 2025
Right Censoring and Mortality in the Multicenter AIDS Cohort Study and Women's Interagency HIV StudyJessie K Edwards, Tiffany L Breger, Stephen R Cole, et al.
Implementation Science Communications|July 28, 2025
Study design and procedures for a hybrid effectiveness-implementation incomplete stepped-wedge cluster-randomized trial to evaluate a differentiated point-of-care HIV diagnosis and management model for the prevention of vertical transmission of HIV in Malawi: The PAC-Man trial protocolMichael E Herce, Caitlin Cassidy, Alexandra Munson, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Nature Communications|July 8, 2021
The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the CongoNicholas F Brazeau, Cedar L Mitchell, Andrew P Morgan, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
JAMA Network Open|October 13, 2022
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the USRaynell Lang, Elizabeth Humes, Sally B Coburn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2025
Incidence of statin initiation among people with and without HIV in the US: a prospective observational studyTiffany L Breger, Daniel J Westreich, Andrew Edmonds, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Pageof 126